InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact science with reduced financing risk. INM-901 takes a multi-pathway approach to Alzheimer’s, targeting several core drivers of the disease rather…
Perth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced completion of a high-resolution underground Light Detection…
The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by…
Steve Penny, founder of SilverChartist.com, explains why he currently has a bullish outlook for gold, silver and platinum, as…
John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices and stocks.…
American Rare Earths Limited (ARR:AU) has announced Optimisation Update Download the PDF here. This post appeared first on investingnews.com
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) completed the first tranche of its…
(TheNewswire) Vancouver, British Columbia TheNewswire – November 10, 2025 Juggernaut Exploration Ltd (JUGR.V) (OTCPK: JUGRF) (FSE: 4JE) ( the…